Endometrial Cancer Trial, Recruiting (NCT06862102)

Endometrial Cancer Trial, Recruiting NCT06862102 Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06862102 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your cervical smear (Pap smear) test showed abnormal cells that a doctor has recommended need further investigation with a colposcopy (a closer examination of the cervix) and an HPV test
You have an abnormal lesion (unusual tissue growth) on your vagina or vulva that is linked to HPV (Human Papillomavirus)
You have been diagnosed through a biopsy with abnormal cervical cells (CIN) or early-stage cervical cancer that has not progressed beyond a certain early stage (confirm with trial site)

Who may not be able to join:

You are currently pregnant
You are under 18 years of age
You have received treatment in the last 5 years for an HPV-related lesion on your vagina, vulva, or cervix

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390382503720

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06862102

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: +390382503720

More information: https://clinicaltrials.gov/study/NCT06862102

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your cervical smear (Pap smear) test showed abnormal cells that a doctor has recommended need further investigation with a colposcopy (a closer examination of the cervix) and an HPV test
You have an abnormal lesion (unusual tissue growth) on your vagina or vulva that is linked to HPV (Human Papillomavirus)
You have been diagnosed through a biopsy with abnormal cervical cells (CIN) or early-stage cervical cancer that has not progressed beyond a certain early stage (confirm with trial site)

Who may not be able to join:

You are currently pregnant
You are under 18 years of age
You have received treatment in the last 5 years for an HPV-related lesion on your vagina, vulva, or cervix

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Registry

ClinicalTrials.gov

Start date

8 January 2021

Est. completion

28 February 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

effect of HPV vaccination on multiple HPV infection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov